Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. China In-Vitro Fertilization Market


6. Market Share
6.1 By Treatment Type
6.2 By Analysis
6.3 By Procedure
6.4 By End User


7. Treatment Types
7.1 Fresh Embryo
7.2 Frozen Embryo
7.3 Donor Egg
7.4 Others


8. Instrument
8.1 Culture Media
8.2 Disposable Devices
8.3 Capital Equipment


9. Procedure
9.1 ICSI IVF
9.2 Non-ICSI IVF
9.3 IUI Canada


10. End User
10.1 Fertility Clinics
10.2 Hospitals
10.3 Others


11. Porter’s Five Forces
11.1 Bargaining Power of Buyer
11.2 Bargaining Power of Supplier
11.3 Threat of New Entrants
11.4 Rivalry among Existing Competitors
11.5 Threat of Substitute Products


12. SWOT Analysis
12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats


13. Key Players Analysis
13.1 Vitrolife
13.1.1 Overviews
13.1.2 Recent Developments
13.1.3 Revenues

13.2 Cloudnine
13.2.1 Overviews
13.2.2 Recent Developments
13.2.3 Revenues

13.3 Nova IVI Fertility
13.3.1 Overviews
13.3.2 Recent Developments
13.3.3 Revenues

13.4 Monash ivf
13.4.1 Overviews
13.4.2 Recent Developments
13.4.3 Revenues

13.5 Maria Fertility Hospital
13.5.1 Overviews
13.5.2 Recent Developments
13.5.3 Revenues

13.6 Bangkok Fertility Center
13.6.1 Overviews
13.6.2 Recent Developments
13.6.3 Revenues

13.7 EMD Serono, Inc
13.7.1 Overviews
13.7.2 Recent Developments
13.7.3 Revenues



List of Figures

0

List of Tables

0